Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05768217 · ClinicalTrials.gov registry record · NA

Community Resiliency Collective Efficacy Intervention

A NA study of Violence in Adolescence and Violence, Domestic, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
4,600
Enrollment target
1
Study location

NCT05768217 is a NA study of Violence in Adolescence and Violence, Domestic that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 4,600 participants, above the 272-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (1591% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05768217, a NA study of Violence in Adolescence and Violence, Domestic, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
4,600 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

Interventions

  • BEHAVIORAL Community Resiliency Collective Efficacy Intervention (CRCEI)
  • BEHAVIORAL Health Education Sessions

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 4,600 participants
Start Date 2024-06-24
Est. Completion 2027-09-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05768217

The ClinicalTrials.gov registry entry for NCT05768217 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 4,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 272-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (1591% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Violence in Adolescence appearing as the primary indexed condition, and to 2 interventions - of which Community Resiliency Collective Efficacy Intervention (CRCEI) is the first listed.

NCT05768217 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05768217 about?

NCT05768217 is a clinical study titled "Community Resiliency Collective Efficacy Intervention". This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

What is the current status of trial NCT05768217?

This trial is currently recruiting. It is a NA study. The enrollment target is 4,600 participants. The study started on 2024-06-24. Estimated completion is 2027-09-30.

What conditions does trial NCT05768217 study?

This clinical trial studies the following conditions: Violence in Adolescence, Violence, Domestic, Violence, Physical, Violence, Sexual, Violence, Non-accidental.

What interventions are being tested in trial NCT05768217?

The interventions under investigation include: Community Resiliency Collective Efficacy Intervention (CRCEI) (BEHAVIORAL), Health Education Sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT05768217?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05768217 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence in Adolescence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.